Working Group on Pediatric Sleep Medicine, Department of Neonatology, University Children's Hospital Tuebingen, Calwer Str. 7, 72076 Tuebingen, Germany.
Sleep Med Rev. 2013 Oct;17(5):331-40. doi: 10.1016/j.smrv.2012.08.004. Epub 2013 Jan 30.
To investigate diagnostic test accuracy (DTA) of different tests for obstructive sleep apnea (OSA) compared to polysomnography (PSG) in children.
We performed a systematic review according to DTA criteria published by the Cochrane Collaboration. Studies that compared any possible diagnostic test with PSG for diagnosing OSA were considered. Study quality assessment was conducted in each selected study and DTA measures recalculated by hand whenever possible. Excellent DTA was defined as positive likelihood ratio (PLR) > 10 and negative likelihood ratio (NLR) < 0.1.
We identified 1064 potentially relevant studies, of which 33 met inclusion criteria. Study quality was generally low; 5 studies fulfilled all quality criteria and 11 studies included >100 subjects. Included studies compared 40 different tests to PSG. Only 13 studies used the currently accepted definition for OSA (i.e., apnea hypopnea index ≥1). In these studies, PLR ranged from 1.017 to ∞, NLR from 0 to 1.089. Sleep lab-based polygraphy, urinary biomarkers, and rhinomanometry (one study each) showed excellent DTA.
There is limited evidence concerning diagnostic alternatives to PSG for identifying OSA in children. However, polygraphy, urinary biomarkers, and rhinomanometry may be valid tests if their apparently high DTA is confirmed by subsequent studies.
研究比较不同测试与多导睡眠图(PSG)相比,在儿童阻塞性睡眠呼吸暂停(OSA)中的诊断测试准确性(DTA)。
我们根据 Cochrane 协作组发布的 DTA 标准进行了系统评价。考虑了将任何可能的诊断测试与 PSG 进行比较以诊断 OSA 的研究。对每个选定的研究进行了研究质量评估,并在可能的情况下手动重新计算 DTA 测量值。优秀的 DTA 定义为阳性似然比(PLR)>10 和阴性似然比(NLR)<0.1。
我们确定了 1064 篇潜在相关的研究,其中 33 篇符合纳入标准。研究质量普遍较低;5 项研究符合所有质量标准,11 项研究纳入了>100 名受试者。纳入的研究将 40 种不同的测试与 PSG 进行了比较。只有 13 项研究使用了目前公认的 OSA 定义(即呼吸暂停低通气指数≥1)。在这些研究中,PLR 范围从 1.017 到∞,NLR 从 0 到 1.089。睡眠实验室多导睡眠图、尿生物标志物和鼻阻力计(各有一项研究)显示出出色的 DTA。
关于 PSG 替代方法在儿童中识别 OSA 的诊断替代方法的证据有限。然而,如果后续研究证实了这些测试明显较高的 DTA,则多导睡眠图、尿生物标志物和鼻阻力计可能是有效的测试。